Werewolf Therapeutics to Present Data From Ongoing Phase 1/1B Clinical Trial of Wtx-124 as Monotherapy and in Combination With Pembrolizumab in Solid Tumors
Werewolf Therapeutics將提供正在進行的Wtx-124作爲單一療法以及與Pembrolizumab聯合治療實體瘤的1/1B期臨床試驗的數據
Werewolf Therapeutics to Present Data From Ongoing Phase 1/1B Clinical Trial of Wtx-124 as Monotherapy and in Combination With Pembrolizumab in Solid Tumors
Werewolf Therapeutics將提供正在進行的Wtx-124作爲單一療法以及與Pembrolizumab聯合治療實體瘤的1/1B期臨床試驗的數據
譯文內容由第三人軟體翻譯。